Search results
Results from the WOW.Com Content Network
A BI-RADS classification of 4 or 5 warrants biopsy to further evaluate the offending lesion. [3] Some experts believe that the single BI-RADS 4 classification does not adequately communicate the risk of cancer to doctors and recommend a subclassification scheme: [4] 4A: low suspicion of malignancy, about > 2% to ≤ 10% likelihood of malignancy
Like the triple test score, BI-RADS (breast imaging-reporting and data system) uses a similar method of scoring breast imaging reports to help with evaluating and determining treatment for breast masses. [8] Like the triple test score, BI-RADS employs a numerical scoring system to determine whether a mass is benign or malignant.
Minimal residual disease (MRD), also known as Molecular residual disease, is the name given to small numbers of cancer cells that remain in a person either during or after treatment when the patient is in remission (no symptoms or signs of disease). Sensitive molecular tests are either in development or available to test for MRD.
The Mayo Clinic Cancer Center is one of the oldest NCI-designated cancer centers in the United States, having first been designated in 1973. [3] The main location of the Mayo Clinic is in Rochester, MN. Campuses in Arizona and Florida opened later and became part of the Mayo Clinic Cancer Center in 2003. [4] [5] Mayo receives more than $100 ...
The use of this treatment type largely depends on the fact that malignant and normal cells have differing responses to the energy source used. [21] This dependency is due to the intracellular changes which occur during hyperthermia; as the nucleic acids , cell membrane and cytoskeleton within each cell is affected indirectly and/or through ...
Children living near the Chernobyl nuclear power plant during the catastrophe of 1986 experienced a 60-fold increase in the incidence of thyroid cancer. Thyroid cancer arising in the background of radiation is often multifocal with a high incidence of lymph node metastasis and has a poor prognosis. [citation needed]
Chemical messengers such as hormones bind to receptors, and this causes changes in the cell. Breast cancer cells may or may not have many different types of receptors, the three most important in the present classification being: estrogen receptor (ER), progesterone receptor (PR), and HER2/neu. Cells with or without these receptors are called ...
Paget's disease of the breast is a symptom of underlying breast cancer. Treatment is variable and is determined by the type of breast cancer in addition to its staging and prognostic considerations. Management often involves a lumpectomy or mastectomy to surgically remove the tumour. [12] Chemotherapy and/or radiotherapy may also be necessary. [13]